tm logo
CYCART19
Live/Registered
REGISTERED

on 30 May 2023

Last Applicant/ Owned by

170 Park Avenue

Florham Park

NJ

07032

Serial Number

90766689 filed on 10th Jun 2021

Registration Number

7064864 registered on 30th May 2023

in the Principal Register

Correspondent Address

CAMILLE M. MILLER

Camille M. Miller

1650 MARKET STREET

SUITE 2800

PHILADELPHIA, PA 19103

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

CYCART19

bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research; placental-derived cells, chimeric antigen receptor (CAR) T cells, and placental-derived T cells with a chimeric antigen receptor (CAR), all for use in scientific, laboratory and medical researc Read More

Classification Information


Class [001]
Chemical Products


bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research; placental-derived cells, chimeric antigen receptor (CAR) T cells, and placental-derived T cells with a chimeric antigen receptor (CAR), all for use in scientific, laboratory and medical research


First Use Date in General

07th Jan 2020

First Use Date in Commerce

02th Jun 2021

Class [005]
Pharmaceutical Products


Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, placental-derived cells, umbilical cord cells, placental-derived T cells, chimeric antigen receptor (CAR) T cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; biological tissue intended for use as a wound covering and burn dressing; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds and burns; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen


First Use Date in General

07th Jan 2020

First Use Date in Commerce

02th Jun 2021

Specimens


CYCART19 specimenCYCART19 specimen

Mark Details


Serial Number

No 90766689

Mark Type

No Service/Collective Mark

Attorney Docket Number

No CLTY-2123US/

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
30th May 2023REGISTERED-PRINCIPAL REGISTER
30th May 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
14th Mar 2023PUBLISHED FOR OPPOSITION
14th Mar 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22nd Feb 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06th Feb 2023APPROVED FOR PUB - PRINCIPAL REGISTER
03rd Feb 2023EXAMINER'S AMENDMENT ENTERED
03rd Feb 2023EXAMINERS AMENDMENT -WRITTEN
03rd Feb 2023EXAMINERS AMENDMENT E-MAILED
03rd Feb 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED